2023-09206. Advancing the Utilization and Supporting the Implementation of Innovative Manufacturing Approaches; Public Workshop; Request for Comments; Correction  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice of public workshop; request for comments; correction.

    SUMMARY:

    The Food and Drug Administration is correcting a notice entitled “Advancing the Utilization and Supporting the Implementation of Innovative Manufacturing Approaches” that appeared in the Federal Register of April 24, 2023. The document announced a public workshop. The document was published with an incorrect topic for discussion. This document corrects that error.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Lisa Granger, Office of Policy, Legislation, and International Affairs, Food and Drug Administration, 301–796–9115, Lisa.Granger@fda.hhs.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In the Federal Register of April 24, 2023, in FR Doc. 2023–08545 (88 FR 24807), on page 24808, the following correction is made:

    • On page 24808, in the second column, in Section II, “Topics for Discussion at the Public Workshop,” the fifth topic, “Science- and risk-based approaches for developing and accessing innovative technologies across platform products and sites to streamline adoption.” is corrected to read “Science- and risk-based approaches for developing and assessing innovative technologies across platform products and sites to streamline adoption.”
    Start Signature

    Dated: April 26, 2023.

    Lauren K. Roth,

    Associate Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. 2023–09206 Filed 5–1–23; 8:45 am]

    BILLING CODE 4164–01–P

Document Information

Published:
05/02/2023
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice of public workshop; request for comments; correction.
Document Number:
2023-09206
Pages:
27522-27522 (1 pages)
Docket Numbers:
Docket No. FDA-2023-N-1259
PDF File:
2023-09206.pdf